• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices

  • Print
  • Share
  • E-mail
-

The inventory of GRAS notices provides information about GRAS notices filed since 1998, when FDA received its first GRAS notice. As of October 17, 2016, the GRAS final rule (81 FR 54960; August 17, 2016) requires a specific format for a GRAS notice. Prior to that date, FDA processed GRAS notices under the framework of the GRAS proposed rule (62 FR 18938; April 17, 1997). Notices received prior to the effective date of the GRAS final rule provide examples for potential notifiers for the types of information that may support a GRAS conclusion. In the inventory, notices follow the requirements for the format and content of a GRAS notice as of the effective date of the GRAS final rule.

The inventory notes what type of response letter the FDA sent in response to the notice. Notifiers often resubmit notices that FDA previously ceased to evaluate at the notifier’s request, and resubmitted notices commonly receive a letter indicating FDA has no questions, after addressing deficiencies. In the inventory, entries for notices that were later resubmitted link to the newer entry in the final column. Newer entries for notices that were resubmitted include a link to the previous submission below the substance name.

Some GRNs that FDA previously ceased to evaluate at the notifier’s request were later resubmitted as a food additive petition. For each of these cases, the GRN detail page links to the food additive petition.

After issuing a response letter, we may issue a subsequent letter as circumstances warrant. The issue dates of any subsequent letters are listed under the column, "Date of add’l correspondence.”

We will update this information approximately monthly. More information about this inventory is available on the GRAS Notice Inventory Introduction page.


Search and display hints:

  • Select the specific GRN number below to view additional details about any GRAS Notice.
  • To sort by a specific field, click on the column header for that field.
  • To browse the records, use the Show All, First/Previous/Next/Last, and Jump To options at the bottom of the data table.
  • To search for a specific substance/term, enter the term in the Search box and select Show Items to display only those records that contain the selected term. (The search results also includes terms not shown on this page, but included in the full record on the detail page.)
  • The search results will return hits of records containing words that include the search term. For example, a search for the color red will return results that include terms such as reduce, ingredient, and cultured. To limit results to only the searched term, place a space before and after the word in the basic search or in the advanced search “this exact phrase” field.
Download GRAS Notices data in Microsoft Excel web format Download data from this searchable database in Excel format. If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Search within these results
Records Found: 1219 Show All Page 1 of 25
GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
  1219
Recombinant bovine lactoferrin isolate produced by Komagataella phaffii Pending
  1218
Bacillus subtilis NRRL 68054 Pending
  1217
Algal oil (≥40% docosahexaenoic acid) from Aurantiochytrium limacinum CCAP A1 Pending
  1216
Galacto-oligosaccharides Pending
  1215
Bacteriophage (phage) preparation specific to Listeria monocytogenes Pending
  1214
Bacillus clausii UBBC-07 spore preparation Pending
  1213
Goat lactose Pending
  1212
Liquid whole goat milk Pending
  1211
Reduced minerals goat whey Pending
  1210
Glucosyltransferase enzyme preparation produced by Bacillus subtilis expressing the gene encoding glucosyltransferase from Streptococcus salivarius Pending
  1209
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium limacinum A2 Pending
  1208
Lacto-N-triose II Pending
  1207
Brazzein preparation produced by Aspergillus oryzae 90402 expressing a gene encoding for brazzein from Pentadiplandra brazzeana Pending
  1206
Rebaudioside M produced by enzymatic treatment of rebaudioside A purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Pending
  1205
Lactiplantibacillus plantarum DR7 Pending
  1204
Lacticaseibacillus casei Zhang Pending
  1203
Rebaudioside M2 obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni Pending
  1202
Soy leghemoglobin preparation from a strain of Komagataella phaffii Pending
  1201
Lipase enzyme preparation produced by Komagataella phaffii expressing a gene encoding lipase from Yarrowia lipolytica Pending
  1200
β-lactoglobulin produced by Komagataella phaffii strain “VIPLA” Pending
  1199
Rhamnogalacturonan-I Pending
  1198
Inositol Pending
  1197
Fructanase enzyme preparation produced by Trichoderma reesei AR-577 expressing the gene encoding fructanase from Lactobacillus crispatus
   (Resubmission of GRN 1121)
Pending
  1196
Triacylglycerol lipase enzyme preparation produced by Trichoderma reesei expressing a gene encoding an engineered triacylglycerol lipase from Thermomyces lanuginosus
   (Resubmission of GRN 1150)
Pending
  1195
Chymosin enzyme preparation produced by Aspergillus niger expressing a gene encoding chymosin from Erinaceus europaeus Pending
  1194
Partially hydrolyzed eggshell membrane powder derived from chicken eggs Pending
  1193
D-psicose Pending
  1192
Tannase enzyme preparation produced by Aspergillus oryzae Pending
  1191
Ergothioneine produced by Escherichia coli BL-21 (DE3) expressing ergothioneine synthases from Schizosaccharomyces pombe Pending
  1190
Saccharomyces cerevisiae strain OYR-481 expressing a gene encoding acetolactate decarboxylase from Brevibacillus brevis Pending
  1189
Dry whole goat milk Pending
  1188
D-psicose Pending
  1187
Polygalacturonase enzyme preparation produced by Trichoderma reesei expressing a gene encoding polygalacturonase from Aspergillus luchuensis mut kawachii
   (Resubmission of GRN 1110)
Pending
  1186
Fungal oil (≥38% arachidonic acid (ARA)) from Mortierella alpina FJRK-MA01 Pending
  1185
Algal oil (≥35% docosahexaenoic acid) from Schizochytrium sp. FJRK-SCH3 Pending
  1184
Rebaudioside M from a modified strain of Escherichia coli BL21(DE3) Pending
  1183
Monellin preparation produced by Komagataella phaffii P-MON-040 expressing a gene encoding for a modified monellin Pending
  1182
Hydroxytyrosol
   (Resubmission of GRN 1138)
Pending
  1181
Weizmannia coagulans LMG S-31876 spore preparation Pending
  1180
Cellobiose Pending
  1179
Liquid whole cow milk Sep 24, 2024 FDA has no questions (in PDF) (282 kB)
  1178
Rebaudioside I obtained by enzymatic treatment of steviol glycosides purified from the leaves of Stevia rebaudiana (Bertoni) Bertoni (rebaudioside I) Pending
  1177
Bacillus coagulans “Unique IS-2” spore preparation Pending
  1176
Lacto-N-tetraose Pending
  1175
Lactiplantibacillus plantarum DSM 23881 Pending
  1174
Dry whole goat milk Pending
  1173
Invertase enzyme preparation produced by Trichoderma reesei expressing a gene for invertase from Aspergillus niger Pending
  1172
liquid milk, both whole and nonfat, combined with lactose and water May 20, 2024 FDA has no questions (in PDF) (228 kB)
  1171
Non-animal type 21 collagen polypeptide Pending
  1170
Resistant dextrin from tapioca in powder or syrup form Pending

Show All 

jump to page of 25 


GRN No.
(sorted Z-A)
Substance Date of closure FDA's Letter Date of add'l correspondence Resubmitted as GRN No.
-
-